Advertisement
Screener

Amphastar Pharmaceuticals, Inc. (AMPH) Patents: Active

Amphastar Pharmaceuticals, Inc. Active Patents

22 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2025-07-10: Application 19265888; Invention ALBUTEROL AEROSOL SUSPENSION FORMULATION FOR ORAL INHALATION WITH HIGH AMOUNT OF GREEN PROPELLANT HYDROFLUOROOLEFIN (HFO) AND FREE OF CO-SOLVENT; Applicant Amphastar Pharmaceuticals, Inc.; Status Patented Case.
  • 2025-01-06: Application 19011043; Invention ALBUTEROL AEROSOL SUSPENSION FORMULATION FOR ORAL INHALATION WITH HIGH AMOUNT OF GREEN PROPELLANT HYDROFLUOROOLEFIN (HFO) AND FREE OF CO-SOLVENT; Applicant Amphastar Pharmaceuticals, Inc.; Status Patented Case.
  • 2024-07-31: Application 18790336; Invention STABLE EPINEPHRINE SUSPENSION FORMULATION FOR INHALATION WITH HFO PROPELLANT; Applicant Amphastar Pharmaceuticals, Inc.; Status Patented Case.
  • 2023-02-10: Application 18167260; Invention NASAL POWDER FORMULATION FOR TREATMENT OF HYPOGLYCEMIA; Applicant AMPHASTAR PHARMACEUTICALS, INC.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2025-07-1019265888ALBUTEROL AEROSOL SUSPENSION FORMULATION FOR ORAL INHALATION WITH HIGH AMOUNT OF GREEN PROPELLANT HYDROFLUOROOLEFIN (HFO) AND FREE OF CO-SOLVENTAmphastar Pharmaceuticals, Inc.Patented Case2026-06-0212642779
Jack Yongfeng ZHANG
Ying WANG
Ray Lameng LEI
Mary Zi-ping LUO
United States
United States
United States
United States
AZPURU, CARLOS A
2025-01-0619011043ALBUTEROL AEROSOL SUSPENSION FORMULATION FOR ORAL INHALATION WITH HIGH AMOUNT OF GREEN PROPELLANT HYDROFLUOROOLEFIN (HFO) AND FREE OF CO-SOLVENTAmphastar Pharmaceuticals, Inc.Patented Case2025-08-1212383516
Jack Yongfeng ZHANG
Ying WANG
Ray Lameng LEI
Mary Zi-ping LUO
United States
United States
United States
United States
AZPURU, CARLOS A
2024-07-3118790336STABLE EPINEPHRINE SUSPENSION FORMULATION FOR INHALATION WITH HFO PROPELLANTAmphastar Pharmaceuticals, Inc.Patented Case2025-12-1612496272
Jack Yongfeng ZHANG
Mary Zi-ping LUO
Ying WANG
Ray Lameng LEI
Christos LYMBEROPOULOS
Tielong GAO
United States
United States
United States
United States
United States
United States
TRUONG, QUANGLONG N
2023-02-1018167260NASAL POWDER FORMULATION FOR TREATMENT OF HYPOGLYCEMIAAMPHASTAR PHARMACEUTICALS, INC.Patented Case2025-07-2912370241US20230302093A1
Sankaram MANTRIPRAGADA
Claude A. PICHE
Jo Jan Filip VAN BETSBRUGGE
United States
United States
United States
AUDET, MAURY A
2022-10-2817976111INJECTABLE EPINEPHRINE FORMULATIONS DEMONSTRATING STABILITY OVER TIMEAmphastar Pharmaceuticals, Inc.Patented Case2026-03-0312564562US20230140033A1
Jack Yongfeng Zhang
Mary Zi-ping Luo
Fonda Su
Marvin Lin
Jie Fei Ding
Justin Jun Wei
Wenbo Yu
Rong Zhou
United States
United States
United States
United States
United States
United States
United States
United States
SAMSELL, RILLA MARIE
2022-10-2517921235SMALL ANGLE X-RAY SCATTERING METHODS FOR CHARACTERIZING THE IRON CORE OF IRON CARBOHYDRATE COLLOID DRUG PRODUCTSAmphastar Pharmaceuticals, Inc.Patented Case2023-08-1511726049US20230124114A1
Jack Yongfeng ZHANG
Mary Zi-Ping LUO
Thang Kien CHIU
Anthony MARRS
Selina SU
United States
United States
United States
United States
United States
FAYE, MAMADOU
2021-10-2517606214METHOD FOR PREPARING STABLE PEPTIDE FORMULATIONSAmphastar Pharmaceuticals, Inc.Patented Case2025-12-3012508229US20220192988A1
Gregory Nelson Brown
Kurt Gard Van Scoik
United States
United States
SHOMER, ISAAC
2021-03-1217275821NOVEL PRO-INSULIN ASPART STRUCTURE AND METHOD FOR PREPARING INSULIN ASPARTAMPHASTAR NANJING PHARMACEUTICALS INCPatented Case2025-06-1012325732US20210332100A1
Chuangen TANG
Shangshu PAN
Xiaorui LIU
Cheng LI
Huaiyan CUI
Song CHEN
Haoning ZHANG
Jeffrey DING
China
China
China
China
China
China
China
China
ESPINOSA, CLAUDIA EDILMA
2020-08-2116999446MEDICATION DELIVERY SYSTEMS AND METHODSAmphastar Pharmaceuticals, Inc.Patented Case2024-03-2611938089US20200375845A1
Jaime Ray ARNETT
Andrew Thomas SNOW
United States
United States
HUSSAIN, NIDAH MAHREEN
2020-03-1116646506PREPARATION METHOD FOR HIGH PURITY RACEMIC ADRENALINEAMPHASTAR NANJING PHARMACEUTICALS INC.Patented Case2020-10-0610793512US20200270199A1
Yin WANG
Aoxiang ZHANG
Yonggang XU
Song CHEN
Haoning ZHANG
China
China
China
China
China
MURESAN, ANA Z
2019-09-2516583125HIGHLY PURIFIED RECOMBINANT HUMAN INSULIN (RHI) API AND METHODS OF PRODUCING THE SAMEAmphastar Pharmaceuticals, Inc.Patented Case2022-12-1311524987US20200216511A1
Jie Fei Ding
Aili Bo
Jack Yongfeng Zhang
Mary Zi-ping Luo
Zhongli Bao
United States
United States
United States
United States
United States
LIEB, JEANETTE M
2019-08-2816553681HIGH-PURITY INHALABLE PARTICLES OF INSULIN AND INSULIN ANALOGUES, AND HIGH-EFFICIENCY METHODS OF MANUFACTURING THE SAMEAmphastar Pharmaceuticals, Inc.Patented Case2022-09-2011446360US20190388514A1
Jeffrey Ding
Aili Bo
Mary Ziping Luo
Jack Yongfeng Zhang
United States
United States
United States
United States
MARTINEZ, TARA L
2019-07-0316502033METHOD FOR PREPARING LIRAGLUTIDE INTERMEDIATE POLYPEPTIDEAMPHASTAR NANJING PHARMACEUTICALS INC.Patented Case2020-12-0110851146US20190359675A1
Shangshu PAN
Chuangen TANG
Cheng LI
Xiaorui LIU
Huaiyan CUI
Song CHEN
Haoning ZHANG
China
China
China
China
China
China
China
D' AMBROSIO, THEA
2019-03-1916358460METHODS OF RESOLVING RACEMIC MIXTURE TO OBTAIN (-)-HUPERZINE AAMPHASTAR NANJING PHARMACEUTICALS INC.Patented Case2020-11-1010829455US20190210972A1
Yonggang Xu
Hao Wei
Song Chen
Haoning Zhang
China
China
China
China
DESAI, RITA J
2019-02-0416266640NASAL POWDER FORMULATION FOR TREATMENT OF HYPOGLYCEMIAAmphastar Pharmaceuticals, Inc.Patented Case2025-02-1812226456US20190282666A1
Sankaram Mantripragada
Claude A. Piche
Jo Jan Filip Van Betsbrugge
United States
Canada
Canada
AUDET, MAURY A
2016-09-2915280508HIGH-PURITY INHALABLE PARTICLES OF INSULIN AND INSULIN ANALOGUES, AND HIGH-EFFICIENCY METHODS OF MANUFACTURING THE SAMEAmphastar Pharmaceuticals Inc.Patented Case2019-09-1010406210US20170196942A1
Jeffrey Ding
Aili Bo
Mary Ziping Luo
Jack Yongfeng Zhang
United States
United States
United States
United States
YANG, KAIPEEN E
2016-01-0714990787HIGH-PURITY INHALABLE PARTICLES OF INSULIN AND INSULIN ANALOGUES, AND HIGH-EFFICIENCY METHODS OF MANUFACTURING THE SAMEAMPHASTAR PHARMACEUTICALS INC.Patented Case2019-06-1810322168US20170196941A1
Jeffrey Ding
Aili Bo
Mary Ziping Luo
Jack Yongfeng Zhang
United States
United States
United States
United States
YANG, KAIPEEN E
2015-07-0814794766MICRONIZED INSULIN AND MICRONIZED INSULIN ANALOGUES PREPARED UNDER ACIDIC CONDITIONS, AND METHODS OF MANUFACTURING THE SAME UNDER ACIDIC CONDITIONSAMPHASTAR PHARMACEUTICALS INC.Patented Case2019-04-1610258573US20160008287A1
Jeffrey Ding
Aili Bo
Mary Ziping Luo
Jack Yongfeng Zhang
United States
United States
United States
United States
FISCHER, JOSEPH
2015-06-2614752664METHODS OF RESOLVING RACEMIC MIXTURE TO OBTAIN (-)-HUPERZINE AAMPHASTAR PHARMACEUTICALS INC.Patented Case2019-05-1410287249US20160096808A1
Yonggang Xu
Hao Wei
Song Chen
Haoning Zhang
China
China
China
China
DESAI, RITA J
2015-05-1514714196METHOD OF PREPARING INTERMEDIATE OF SALMETEROLAMPHASTAR PHARMACEUTICALS INC.Patented Case2016-09-209447067US20160096816A1
Yinhua Qiu
Zhengyuan Wu
Song Chen
Haoning Zhang
China
China
China
China
DANIEL, LAURA M
2015-05-1514714191METHOD OF PURIFYING IDRAPARINUX SODIUMAMPHASTAR PHARMACEUTICALS INC.Patented Case2018-01-239873712US20160096856A1
Jundong Meng
Yonggang Xu
Wencun Wang
Song Chen
Haoning Zhang
China
China
China
China
China
SHIAO, YIH-HORNG
2015-04-1614688960METHODS OF PREPARING INTERMEDIATE OF FLUTICASONE PROPIONATEAMPHASTAR PHARMACEUTICALS INC.Patented Case2016-04-059303060US20160096863A1
Yinhua Qiu
Zhengyuan Wu
Yong Liu
Song Chen
Haoning Zhang
China
China
China
China
China
ZUCKER, PAUL A

Similar stocks

Stock NameCountryMarket CapPE Ratio
Seaport Therapeutics, Inc. (SPTX)United States$1.131B
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
MANNKIND CORP (MNKD)United States$1.058B-30.41
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Jaguar Health, Inc. (JAGX)United States$1.184B
Savara Inc (SVRA)United States$1.044B-9.10
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87